Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking

Molecules

Volumn 17, Issue 9, 2012, Pages 10142-10158

  Imramovsky, Ales ^a   Stepankova, Sarka ^a   Vanco, Jan ^b   Pauk, Karel ^a   Monreal Ferriz, Juana ^c   Vinsova, Jarmila ^c   Jampilek, Josef ^b  

^a UNIVERSITY OF PARDUBICE   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

4 chloro 2 (chlorophenylcarbamoyl)phenyl alkylcarbamates; In vitro acetylcholinesterase inhibition; Lipophilicity; Molecular docking

Indexed keywords

ACETYLCHOLINESTERASE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; GALANTAMINE; RIVASTIGMINE; SALICYLANILIDE; SALICYLANILIDE DERIVATIVE;

ANIMAL; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; ELECTROPHORUS; ENZYME ACTIVE SITE; METABOLISM; MOLECULAR DOCKING; STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINESTERASE; ANIMALS; BINDING SITES; CARBAMATES; CATALYTIC DOMAIN; CHOLINESTERASE INHIBITORS; ELECTROPHORUS; GALANTAMINE; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; PHENYLCARBAMATES; SALICYLANILIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84866899290     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules170910142     Document Type: Article

References (50)

1. Roth, H.J.; Fenner, H. Arzneistoffe, 3rd ed.; Deutscher Apotheker Verlag: Stuttgart, Germany, 2000.
2. Vinsova, J.; Imramovsky, A. Salicylanilides: Still a topical potential antibacterially active group. Ces. Slov. Farm. 2004, 53, 294-299.
3. Vinsova, J.; Imramovsky, A.; Buchta, V.; Ceckova, M.; Dolezal, M.; Staud, F.; Jampilek, J.; Kaustova, J. Salicylanilide acetates: Synthesis and antibacterial evaluation. Molecules 2007, 12, 1-12.
4. Imramovsky, A.; Vinsova, J.; Ferriz, J.M.; Dolezal, R.; Jampilek, J.; Kaustova, J.; Kunc, F. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains. Bioorg. Med. Chem. 2009, 17, 3572-3579.
5. Imramovsky, A.; Vinsova, J.; Ferriz, J.M.; Buchta, V.; Jampilek, J. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents. Bioorg. Med. Chem. Lett. 2009, 19, 348-351.
6. Ferriz, J.M.; Vavrova, K.; Kunc, F.; Imramovsky, A.; Stolarikova, J.; Vavrikova, E.; Vinsova, J. Salicylanilide carbamates: Antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains. Bioorg. Med. Chem. 2010, 18, 1054-1061.
7. Otevrel, J.; Mandelova, Z.; Pesko, M.; Guo, J.; Kralova, K.; Sersen, F.; Vejsova, M.; Kalinowski, D.; Kovacevic, Z.; Coffey, A.; et al. Investigating the spectrum of biological activity of ring-substituted salicylanilides and carbamoylphenylcarbamates. Molecules 2010, 15, 8122-8142.
8. Imramovsky, A.; Pesko, M.; Ferriz, J.M.; Kralova, K.; Vinsova, J.; Jampilek, J. Photosynthesis-Inhibiting efficiency of 4-chloro-2- (chlorophenylcarbamoyl)phenyl alkylcarbamates. Bioorg. Med. Chem. Lett. 2011, 21, 4564-4567.
9. Rao, V.S. Principles of Weed Science, 2nd ed.; Science Publishers: Enfield, New Hampshire, UK, 2000.
10. Metcalf, R.L. Structure-Activity relationships for insecticidal carbamates. Bull. World Health Org. 1971, 44, 43-54.
11. Zhao, Q.; Yang, G.; Mei, X.; Yuan, H.; Ning, J. Design of novel carbamate acetylcholinesterase inhibitors based on the multiple binding sites of acetylcholinesterase. J. Pestic. Sci. 2008, 34, 371-375.
12. Pejchal, V.; Stepankova, S.; Drabina, P. Synthesis of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2- yl)ethyl]-3-substituted phenyl ureas and their inhibition activity to acetylcholinesterase and butyrylcholinesterase. J. Het. Chem. 2011, 48, 57-62.
13. Pejchal, V.; Stepankova, S.; Padelkova, Z.; Imramovsky, A.; Jampilek, J. 1,3-Substituted imidazolidine-2,4,5-triones: Synthesis and inhibition of cholinergic enzymes. Molecules 2011, 16, 7565-7582.
14. Sundberg, R.J.; Dalvie, D.; Cordero, J.; Sabat, M.; Musallam, H.A. Carbamates of (hydroxyphenoxy)methyl heteroaromatic salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds. Chem. Res. Toxicol. 1993, 6, 500-505.
15. Lin, G.; Liao, W.C.; Chan, C.H.; Wu, Y.H.; Tsai, H.J.; Hsieh, C.W. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates. J. Biochem. Mol. Toxic. 2004, 18, 353-360.
16. Groner, E.; Ashani, Y.; Schorer-Apelbaum, D.; Sterling, J.; Herzig, Y.; Weinstock, M. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates. Mol. Pharmacol. 2007, 71, 1610-1617.
17. Roy, K.K.; Dixit, A.; Saxena, A.K. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis. J. Mol. Graph. Model. 2008, 27, 197-208.
18. Chiou, S.Y.; Huang, C.F.; Hwang, M.T.; Lin, G. Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates. J. Biochem. Mol. Toxic. 2009, 23, 303-308.
19. Chaudhaery, S.S.; Roy, K.K.; Shakya, N.; Saxena, G.; Sammi, S.R.; Nazir, A.; Nath, C.; Saxena, A.K. Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology. J. Med. Chem. 2010, 53, 6490-6505.
20. Greenblatt, H.M.; Dvir, H.; Silman, I.; Sussman, J.L. Acetylcholinesterase: A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease. J. Mol. Neurosci. 2003, 20, 369-383.
21. Soukup, J.E. Alzheimer's Disease: A Guide to Diagnosis, Treatment, and Management; Greenwood Publishing Group: Westport, CT, USA, 1996.
22. Lu, L.C.; Bludau, J. Alzheimer's Disease; Greenwood Publishing Group: Santa Barbara, CA, USA, 2011.
23. Contestabile, A. The history of the cholinergic hypothesis. Behav. Brain Res. 2011, 221, 334-340.
24. Francis, P.T.; Palmer A.M.; Snape, M.; Wilcock, G.K. The cholinergic hypothesis of Alzheimer's disease: A review of progress. J. Neurol. Neurosurg. Psychiatry 1999, 66, 137-147.
25. Imramovsky, A.; Vinsova, J.; Ferriz, J.M.; Kunes, J.; Pour, M.; Dolezal, M. Salicylanilide esterification: Unexpected formation of novel seven-membered rings. Tetrahedron Lett. 2006, 47, 5007-5011.
26. Erkell, L.; Walum, E. Differentiation of cultured neuro-blastoma cells by urea derivates. FEBS Lett. 1979, 104, 401-404.
27. Ellgehausen, H.; D'Hondt, C.; Fuerer, R. Reversed-phase chromatography as a general-method for determing octanol-water partition-coefficients. Pestic. Sci. 1981, 12, 219-227.
28. Briggs, G.J. Theoretical and experimental relationships between soil adsorption, octanol-water partition-coefficients, water solubilities, bioconcentartion factors, and the parachor. Agric. Food Chem. 1981, 29, 1050-1059.
29. Ghose, A.K.; Crippen, G.M. Atomic physicochemical parameters for 3-dimensional-structuredirected quantitative structure-activity-relationships. 2. Modelling dispersive and hydrophobic interactions. J. Chem. Inf. Comput. Sci. 1987, 27, 21-35.
30. Viswanadhan, V.N.; Ghose, A.K.; Revankar, G.R.; Robins, R.K. Atomic physicochemical parameters for 3-dimensional-structure-directed quantitative structure-activity-relationships. 2. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturely-occuring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 1989, 29, 163-172.
31. Broto, P.; Moreau, G.; Vandycke, C. Molecular structures-Perception, auto-correlation descriptor and SAR studies-System of atomic contributions for the calculation of the normal-octanol water partition-coefficients. Eur. J. Med. Chem. Chim. Theor. 1984, 19, 71-78.
32. Hansch, C.; Leo, A.J. Substituent Constants for Correlation Analysis in Chemistry and Biology; Wiley-Interscience: New York, NY, USA, 1979.
33. Davies, J.H.; Campbell, W.R.; Kearns, C.W. Inhibition of fly head acetylcholinesterase by bis-(meta-hydroxphenyl)-trimethylammonium iodide! Esters of polymethylenedicarbamic acid. Biochem. J. 1970, 117, 221-227.
34. Voss, G. Effect of N-alkyl Groups of substituted phenyl-N-alkyl carbamates on inhibition of human-plasma cholinesterase. Arch. Toxicol. 1976, 36, 117-120.
35. Norrington, F.E.; Hyde, R.M.; Williams, S.G.; Wotton, R. Physicochemical-activity relations in practice. 1. Rational and self-consistent data bank. J. Med. Chem. 1975, 18, 604-607.
36. Lin, M.C.; Lin, G.Z.; Shen, Y.F.; Jian, S.Y.; Hsieh, D.K.; Lin, J.; Lin, G. Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as bulky inhibitors of acetylcholinesterase. Chem. Res. Toxicol. 2012, 25, 1462-1471.
37. Sussman, J.L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Atomic-structure of acetylcholinesterase from Torpedo california: A prototypic acetylcholine-binding protein. Science 1991, 253, 872-879.
38. Lin, G.; Liu, Y.C.; Lin, Y.F.; Wu, Y.G. Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates. J. Enzym. Inh. Med. Chem. 2004, 19, 395-401.
39. Lin, G.; Lee, Y.R.; Liu, Y.C.; Wu, Y.G. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase. Chem. Res. Toxicol. 2005, 18, 1124-1131.
40. Kryger, G.; Silman, I.; Sussman, J. Structure of acetylcholinesterase complexed with E2020 (Aricept®): Implications for the design of new anti-Alzheimer drugs. Structure 1999, 7, 297-307.
41. Alonso, I.; Dorronsoro, L.; Rubio, P.; Munoz, E.; Garcia-Palomero, M.; del Monte, A.; Bidon-Chanal, M.; Orozco, F.J.; Luque, A.; Castro, M.; et al. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE. Bioorg. Med. Chem. 2005, 13, 6588-6597.
42. Lin, G.; Chen, G.H.; Lu, C.P.; Yeh, S.C. QSARs for peripheral anionic site of butyrylcholinesterase with inhibitions by 4-acyloxy-biphenyl-4'-N- butylcarbamates. QSAR Comb. Sci. 2005, 24, 943-952.
43. Lin, G.; Chen, G.H.; Yeh, S.C.; Lu, C.P. Probing the peripheral anionic site of acetylcholinesterase with quantitative structure activity relationships for inhibition by biphenyl-4- acyoxylate-4'-N-butylcarbamates. J. Biochem. Mol. Toxicol. 2005, 19, 234-243.
44. Rampa, A.; Bisi, A.; Valenti, P.; Recanatini, M.; Cavalli, A.; Andrisano, V.; Cavrini, V.; Fin, L.; Buriani, A.; Giusti, P. Acetylcholinesterase inhibitors: Synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyhetero aryl derivatives. J. Med. Chem. 1998, 41, 3976-3986.
45. Rampa, A.; Piazzi, L.; Belluti, F.; Gobbi, S.; Bisi, A.; Bartolini, M.; Andrisano, V.; Cavrini, V.; Cavalli, A.; Recanatini, M.; et al. Acetylcholinesterase inhibitors: SAR and kinetic studies on omega-[N-methyl-N- (3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives. J. Med. Chem. 2001, 44, 3810-3820.
46. Paz, A.; Xie, Q.; Greenblatt, H.M.; Fu, W.; Tang, Y.; Silman, I.; Qiu, Z.; Sussman, J.L. Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime. J. Med. Chem. 2009, 52, 7593-7603.
47. Kwok, S.O.; Wang, K.C.; Kwok, H.B. An improved method to determine SH and -S-S- group content in soymilk protein. Food Chem. 2004, 88, 317-320.
48. Sinko, G.; Calic, M.; Bosak, A.; Kovarik, Z. Limitation of the Ellman method: Cholinesterase activity measurement in the presence of oximes. Anal. Biochem. 2007, 370, 223-227.
49. Zdrazilova, P.; Stepankova, S.; Komers, K.; Ventura, K.; Cegan, A. Half-inhibition concentrations of new cholinesterase inhibitors. Z. Naturforsch. 2004, 59, 293-296.
50. Ekstrom, F.; Hornberg, A.; Artursson, E.; Hammarstrom, L.G.; Schneider, G.; Pang, Y.P. Structure of HI-6 center dot sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: Reactivator mechanism and design. PLoS One 2009, 4, e5957.